174 related articles for article (PubMed ID: 25050369)
1. The inhibition of folylpolyglutamate synthetase (folC) in the prevention of drug resistance in Mycobacterium tuberculosis by traditional Chinese medicine.
Hung TC; Chen KB; Lee WY; Chen CY
Biomed Res Int; 2014; 2014():635152. PubMed ID: 25050369
[TBL] [Abstract][Full Text] [Related]
2. Phylogenetic and Structural Significance of Dihydrofolate Synthase (folC) Mutations in Drug-Resistant Mycobacterium tuberculosis.
Cheng VW; Leung KS; Kwok JS; Leung RK; Yang KY; Chan RC; Kam KM; Tsui SK
Microb Drug Resist; 2016 Oct; 22(7):545-551. PubMed ID: 27082669
[TBL] [Abstract][Full Text] [Related]
3. Insight into HIV of IFN-induced myxovirus resistance 2 (MX2) expressed by traditional Chinese medicine.
Hung TC; Lee WY; Chen KB; Chan YC; Chen CY
Biomed Res Int; 2014; 2014():871576. PubMed ID: 25045710
[TBL] [Abstract][Full Text] [Related]
4. In Silico Investigation of Traditional Chinese Medicine for Potential Lead Compounds as SPG7 Inhibitors against Coronary Artery Disease.
Chen KB; Chen KC; Chang YL; Chang KL; Chang PC; Chang TT; Chen YC
Molecules; 2016 May; 21(5):. PubMed ID: 27164068
[TBL] [Abstract][Full Text] [Related]
5. Possible inhibitor from traditional Chinese medicine for the β form of calcium-dependent protein kinase type II in the treatment of major depressive disorder.
Hung TC; Lee WY; Chen KB; Huang HJ; Chan YC; Lee CC; Chen CY
Biomed Res Int; 2014; 2014():761849. PubMed ID: 25045698
[TBL] [Abstract][Full Text] [Related]
6. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
[TBL] [Abstract][Full Text] [Related]
7. Lead screening for CXCR4 of the human HIV infection receptor inhibited by traditional Chinese medicine.
Hung TC; Lee WY; Chen KB; Chen CY
Biomed Res Int; 2014; 2014():809816. PubMed ID: 24999477
[TBL] [Abstract][Full Text] [Related]
8. Virtual screening of traditional Chinese medicine (TCM) database: identification of fragment-like lead molecules for filariasis target asparaginyl-tRNA synthetase.
Arya H; Coumar MS
J Mol Model; 2014 Jun; 20(6):2266. PubMed ID: 24842326
[TBL] [Abstract][Full Text] [Related]
9. Binding of pyrazole-based inhibitors to Mycobacterium tuberculosis pantothenate synthetase: docking and MM-GB(PB)SA analysis.
Ntie-Kang F; Kannan S; Wichapong K; Owono Owono LC; Sippl W; Megnassan E
Mol Biosyst; 2014 Feb; 10(2):223-39. PubMed ID: 24240974
[TBL] [Abstract][Full Text] [Related]
10. A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase.
White EL; Southworth K; Ross L; Cooley S; Gill RB; Sosa MI; Manouvakhova A; Rasmussen L; Goulding C; Eisenberg D; Fletcher TM
J Biomol Screen; 2007 Feb; 12(1):100-5. PubMed ID: 17175524
[TBL] [Abstract][Full Text] [Related]
11. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
[TBL] [Abstract][Full Text] [Related]
12. Comparative modeling and dynamic simulation of UDP-N-acetylmuramoyl-alanine ligase (MurC) from Mycobacterium tuberculosis through virtual screening and toxicity analysis.
Isa MA
Life Sci; 2020 Dec; 262():118466. PubMed ID: 32961233
[TBL] [Abstract][Full Text] [Related]
13. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Devi PB; Samala G; Sridevi JP; Saxena S; Alvala M; Salina EG; Sriram D; Yogeeswari P
ChemMedChem; 2014 Nov; 9(11):2538-47. PubMed ID: 25155986
[TBL] [Abstract][Full Text] [Related]
14. 5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.
Velaparthi S; Brunsteiner M; Uddin R; Wan B; Franzblau SG; Petukhov PA
J Med Chem; 2008 Apr; 51(7):1999-2002. PubMed ID: 18335974
[TBL] [Abstract][Full Text] [Related]
15. Application of fragment growing and fragment linking to the discovery of inhibitors of Mycobacterium tuberculosis pantothenate synthetase.
Hung AW; Silvestre HL; Wen S; Ciulli A; Blundell TL; Abell C
Angew Chem Int Ed Engl; 2009; 48(45):8452-6. PubMed ID: 19780086
[No Abstract] [Full Text] [Related]
16. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
[TBL] [Abstract][Full Text] [Related]
17. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
[TBL] [Abstract][Full Text] [Related]
18. A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.
Yang Y; Gao P; Liu Y; Ji X; Gan M; Guan Y; Hao X; Li Z; Xiao C
Bioorg Med Chem Lett; 2011 Jul; 21(13):3943-6. PubMed ID: 21641210
[TBL] [Abstract][Full Text] [Related]
19. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
20. Mutations of folC cause increased susceptibility to sulfamethoxazole in Mycobacterium tuberculosis.
Wang R; Li K; Yu J; Deng J; Chen Y
Sci Rep; 2021 Jan; 11(1):1352. PubMed ID: 33446754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
